Competing interests
K.S. declares that they are a co-inventor on patents WO2018215818A1 WO2017140778A1 and WO2016131098A1 for NLRP3 inhibitors that have been licensed to Inflazome. Inflazome was acquired by Roche. K.S. has served on the scientific advisory boards of Inflazome, Quench Bio and Novartis. M.M. declares no competing interests.